Hysterectomy: What Needs to be Removed?

Mary Jane Minkin

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

Endometrial Cancer: Risk Factors, Prognostic Challenges, and Staging…

Hope Cottrill

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Current Immunotherapy Treatment Landscape for Advanced/Recurrent End…

City of Hope

M. Song

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

Advancing Precision: Innovations in Minimally Invasive Gynecologic S…

Jessica Opoku-Anane

Comprehensive Review and Treatment Updates in Endometrial Cancer

University of Illinois Cancer Center

J. Ray

ESMO 2024 Insights: Pembro or Placebo in Combination With Adjuvant C…

2024 ESMO Annual Meeting Insights Hub

B. Slomovitz

Early Identification and Management of irAEs in Endometrial Cancer

Debra Richardson

Phase III Trials of Adjuvant Radiotherapy and Chemotherapy in Endome…

GRACE

M. Raza Mirza

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

Optimal Duration of Maintenance IO in Endometrial Cancer

Jose Perez-Fidalgo

The Evolving Treatment Landscape of Advanced Stage & Recurrent Endom…

Scripps Health

R. Eskander